...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens.
【24h】

High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens.

机译:人类乳头瘤病毒16 DNA病毒载量估计值的高度相关性,这是通过对生殖器标本进行的三种实时PCR分析得出的。

获取原文
获取原文并翻译 | 示例
           

摘要

Human papillomavirus-16 (HPV-16) viral load could be a biomarker predictive of the presence of high-grade cervical lesions. Recently, several real-time PCR assays have been developed to accurately measure HPV-16 viral load. However, results from various reports using these assays cannot be compared because interassay test correlation has not been documented. The variability of HPV-16 DNA quantitation was assessed by comparing three real-time PCR assays (HPV-16 L1, HPV-16 E6, and HPV-16 E6 PG) applied on 144 genital samples (125 cervicovaginal lavages and 19 specimens collected using vaginal tampons) obtained from 84 women (66 HIV seropositive and 18 HIV seronegative). Correlation was greater between the HPV-16 E6 assays [correlation coefficient (rho) = 0.92] than between each E6 assay and HPV-16 L1 assay (rho = 0.83 and 0.84, respectively). The median HPV-16 copies measured by HPV-16 E6 PG (14,609 HPV-16 copies/2 muL sample) and HPV-16 E6 (18,846 HPV-16 copies/2 muL) were similar (P = 0.27) but were both greater than the median HPV-16 copies measured with the L1 assay (4,124 HPV-16 copies/2 muL; P < 0.001). Correlations between HPV-16 E6 assays were similar for samples containing non-European (rho = 0.93) or European (rho = 0.95) variants. However, the correlation between HPV-16 L1 and HPV-16 E6 PG or HPV-16 E6 was lower for specimens containing non-European variants (rho = 0.80 and 0.76, respectively) compared with specimens containing European variants (rho > 0.85). HPV-16 DNA quantity estimated with the three assays was comparable although lower with the HPV-16 L1 assay. The level of correlation depended on viral polymorphism, viral load, and cervical disease status.
机译:人类乳头瘤病毒16(HPV-16)病毒载量可能是预测高级别宫颈病变的生物标志物。近来,已经开发了几种实时PCR测定法以精确地测量HPV-16病毒载量。但是,由于没有证明试验间的测试相关性,因此无法比较使用这些试验的各种报告的结果。 HPV-16 DNA定量分析的变异性是通过比较三种实时PCR测定法(HPV-16 L1,HPV-16 E6和HPV-16 E6 PG)评估的,这些测定应用于144个生殖器样本(125例宫颈阴道灌洗液和19例使用阴道收集的宫颈液)阴道棉塞)来自84名妇女(66名HIV血清阳性和18名HIV血清阴性)。 HPV-16 E6检测之间的相关性更大[相关系数(rho)= 0.92],比每种E6检测和HPV-16 L1检测之间的相关性更大(分别为rho = 0.83和0.84)。由HPV-16 E6 PG(14,609 HPV-16拷贝/ 2μL样品)和HPV-16 E6(18,846 HPV-16拷贝/ 2μL)测量的中位HPV-16拷贝相似(P = 0.27),但两者均更大用L1分析测得的中位HPV-16拷贝数为(4,124 HPV-16拷贝/ 2μL; P <0.001)。对于包含非欧洲(rho = 0.93)或欧洲(rho = 0.95)变异的样品,HPV-16 E6分析之间的相关性相似。但是,与包含欧洲变体的样品(rho> 0.85)相比,包含非欧洲变体的样品(rho = 0.80和0.76)的HPV-16 L1和HPV-16 E6 PG或HPV-16 E6之间的相关性较低。三种测定法估计的HPV-16 DNA数量可比,尽管与HPV-16 L1测定法相比较低。相关水平取决于病毒的多态性,病毒载量和宫颈疾病状况。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号